4D Molecular Therapeutics, Inc. Common Stock

FDMTNASDAQ • USD
ThemeGenomics & Precision Med.›Gene Therapy & Gene Editing
10.55 USD
↗ 0.27 (2.63%)AT CLOSE (11:59 AM EDT)
10.66
↗ 0.10 (1.00%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
10.66
↗ 0.10 (1.00%)
🔴Market: CLOSED

Shares of 4D Molecular Therapeutics, Inc. Common Stock (FDMT) are trading at $10.55. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place FDMT at a fair price relative to peers.

Technical & fundamental data as of Aug 6, 2026.

Open?$10.21
High?$10.69
Low?$10.21
Prev. Close?$10.28
Volume?297.3K
Avg. Volume?854.1K
VWAP?$10.46
Rel. Volume?0.35x
Bid / Ask
Bid?$8.47 × 100
Ask?$12.12 × 100
Spread?$3.65
Midpoint?$10.30
Valuation & Ratios
Market Cap?537.4M
Shares Out?52.3M
Float?44.5M
Float %?85.2%
P/E Ratio?N/A
P/B Ratio?1.19
EPS?-$3.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
Themes
Healthcare - Genomics & Precision Medicine›Gene Therapy & Gene EditingBiotech - Drug Development›Clinical-Stage Platforms
Employees
196
Market Cap
537.4M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
www.4dmoleculartherapeutics.com
Listed
2020-12-11
Address
5858 HORTON STREET #455
EMERYVILLE, CA 94608
Phone: (510) 505-2680
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
71
Momentum?
45
Short Sent.?
15
Piotroski F-Score?1/9Weak
Altman Z-Score?3.00Safe
Confidence?57%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?25.52%Squeeze Risk
Short Interest?11.4M
Days to Cover?15.5
Free Float44.5M
Avg Daily Volume732.6K
Settlement Date2026-07-15
Financial Health
Current Ratio?9.34Strong
Quick Ratio?9.34Strong
Cash Ratio?1.67Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
93
1.19CHEAP▾
P/S?
Peers
100
S&P
21
6.09FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.7CHEAP▾
EV/Sales?
Peers
100
S&P
34
5.27FAIR▾
Returns & Efficiency
ROE?
S&P
5
-35.6%WEAK▾
ROA?
S&P
3
-31.4%WEAK▾
Cash Flow & Enterprise
FCF?$-129544000
Enterprise Value?$464.9M
Fundamentals ratios updated end of day
MarketsMoversWatchlist